Webinars & e-learning courses All webinars

Chemotherapy Precautions and Safety - Why, How and What to do (for Nurses)

Chemotherapy Precautions and Safety - Why, How and What to do (for Nurses)
Chemotherapy Precautions and Safety - Why, How and What to do (for Nurses)

Cancer frequently affects our veterinary patients and in recent years chemotherapy has become more commonly utilised treatment. General practices are increasingly prescribing and administering chemotherapy drugs. Chemotherapy drugs are toxic to cells (cytotoxic) interfering with the normal cell life cycle which results in cell death. Cancer cells are targeted by these drugs however they are not specific for cancer cells and healthy tissue can be affected.

Chemotherapy drugs are also carcinogenic, mutagenic, teratogenic and abortifacient. It is important that these drugs are handled safely. Personnel handling of chemotherapeutic drugs have been found to have increased risks of infertility, early pregnancy loss or urinary excretion of these drugs. This webinar will discuss the safety precautions necessary for handling chemotherapy agents and will focus on the recent consensus guidelines produced by the American College of Veterinary Internal Medicine (ACVIM) in January 2018 to raise awareness of risks and how we can reduce the exposure within clinics.

If time permits, common side effects (neutropaenia, thorombocytopaenia and gastrointestinal side effects) caused by chemotherapy will be explained as well as precautions for handling such patients.

Recording from 8 August 2019

Speaker:

BVSCMomokoIto_image.jpg

Momoko Ito

VTS (Oncology)

Momoko is from Japan and moved to Brisbane in 2006. She completed a Bachelor of Veterinary Technology at the University of Queensland in 2011. She has worked in general practice before working at Brisbane Veterinary Specialist Centre. She started as a full-time rotating nurse at BVSC in 2011, then became BVSC's Primary Chemotherapy Nurse in 2013. Momoko also volunteered at the RSPCA Wildlife Hospital every Saturday for one year as well as taking casual shits at the BVECCS Emergency Centre.
In June 2018, Momoko passed the exam to become a Veterinary Technician Specialist (VTS) in Oncology accredited by the Academy of Internal Medicine Veterinary Technicians in the US. She is currently the first and the only VTS (Oncology) in Australia. Her daily goal is to give our patients the best attentions and care, and also to be the better communication bridge between owners and veterinarians to achieve a good quality of life in cancer patients. Her interest is not only limited to Oncology but also Internal Medicine and Feline Behaviour and Handling.
Momoko grew up with 4-6 cats. She admits being a crazy cat lady who also loves dogs. She enjoys yoga, indoor soccer and occasional hiking.

Booking information

Duration: 0:45 h
Speaker: Momoko Ito
from 1
57.60 US$
(inkl. tax)

You might also be interested in

veterinary-gb0489bee6_1920300x200.jpg
Penny Thomas
0:51 h

Supportive Care for Cancer Patients for Nurses

How to provide the best nursing care for patients with cancer 
lumbectomies 300x200.png
Barney Dean
1:07 h

Don't Get Stumped by Lumps - Approaching Tricky Lumpectomies 

In this webinar Barney Dean will discuss the rationale behind sound investigation and management of tricky mass removals, and how to adapt a plan to suit owner circumstances. 
 
canine-and-feline-lymphoma-diagnosis-and-treatment-1.jpeg
Peter Bennett
0:59 h

Canine and feline lymphoma - diagnosis and treatment

Canine and feline lymphoma is a relatively common disease but there are some areas where potential complications arise. This webinar will concentrate on the diagnostic tests that can be utilised for this disease and the common treatments, with an emphasis on how the diagnostic tests can influence the treatment and prognosis. In dogs, diagnosis is usually relatively straightforward, but it can be more of a challenge in cats due to the differences in clinical presentation. The standard initial treatment options are well described, but how they need to be modified dependent on concurrent illnesses, diagnostic test findings and owner constraints can be more complicated. My approach to these issues will be described including how they might impact the patient outcome, as well as alternatives. The monitoring of the patients and an overview of the management of complications of the disease and treatment is to be covered. The webinar will conclude with rescue options. Lymphoma can be a rewarding disease to treat, but can be very challenging at times.